The study, published in Reproductive Sciences by Zhenya Yuan, Jun Shao, Ya Wen and colleagues working across reproductive medicine centers in Xuzhou, Nantong and Kunming, addresses a problem that is particularly acute in China, where PGT-A is subject to strict regulatory limitations. Without access to genetic testing, embryologists must choose which embryos to transfer based on appearance and development alone, yet visual assessment is a notoriously imperfect proxy for chromosomal health. An embryo can look flawless under the microscope and still carry an extra or missing chromosome, while a seemingly mediocre embryo may be genetically normal and fully capable of producing a live birth.

The motivation for avoiding biopsy is not merely regulatory. Although PGT-A is widely used, concerns persist that removing cells from a blastocyst, typically from the trophectoderm that later forms the placenta, could compromise the embryo’s developmental potential. The new study’s authors note that this possibility of harm, combined with the regulatory environment, made a non-invasive predictive approach a clinical necessity rather than a convenience. Their solution draws on data that fertility clinics already collect routinely, meaning the model could in principle be deployed without any change to laboratory workflow.

Technically, the researchers constructed their model using logistic regression, a statistical machine learning method that estimates the probability of a binary outcome, in this case whether a blastocyst is euploid or aneuploid. The team describes the construction as a two-step logistic regression analysis, in which predictor variables were combined to generate a risk score for each embryo. The inputs to the model fell into four categories: the results of PGT-A performed on the training embryos, which served as the ground truth labels; the dynamic development characteristics of the embryos, capturing how quickly and smoothly they progressed through early cleavage stages; the morphology of the blastocysts themselves, including the conventional features embryologists assess under the microscope; and the age of the female patient, which is one of the strongest known determinants of aneuploidy risk.

This combination of features is significant because each captures a different dimension of embryo quality. Morphokinetic data, the timing of developmental events, reflects the pace and coordination of cell divisions, and previous research has linked deviations from normal timing to chromosomal abnormalities. Blastocyst morphology, graded by systems such as the Gardner classification, summarizes the expansion of the embryo and the quality of the inner cell mass and trophectoderm. Female age contributes the statistical prior that chromosomal error rates rise steeply as oocytes age. By weaving these signals together mathematically, the model effectively formalizes what skilled embryologists do intuitively, but does so consistently and with quantified confidence.

The performance figures reported for the model are striking for a non-invasive approach. The area under the receiver operating characteristic curve, a standard measure of a classifier’s ability to distinguish between positive and negative cases across all decision thresholds, reached 0.877. When the model was applied to an independent data set, meaning embryos that played no role in training it, it achieved an accuracy rate of 77.35 percent, a precision rate of 77.49 percent, and a recall rate of 72.55 percent. The f-score, which balances precision and recall into a single number, was 74.94 percent. The model correctly identified aneuploid embryos, the true negative rate from the euploid perspective, 81.55 percent of the time, while producing a false positive rate of 18.45 percent and a false negative rate of 27.45 percent.

Perhaps the most clinically meaningful comparison in the study pits the machine learning model against the tools embryologists actually use. The model’s false positive rate in predicting euploid blastocysts was significantly lower than that of the Gardner grading system, the standard morphology-based classification, and also lower than KIDScore D5, a commercially available time-lapse algorithm that scores embryos based on their developmental dynamics. In practical terms, this means the model was less likely than conventional methods to flag an embryo as euploid when it was not, reducing the risk that patients undergo transfers destined to fail or miscarry.

The researchers went beyond retrospective prediction and examined what happened when the model was used to make real selection decisions. When blastocysts for frozen embryo transfer were chosen using the model’s predictions, the transfer outcomes improved significantly compared with cycles in which embryos were selected by Gardner grade alone. This is a crucial distinction, because a model can score well on statistical metrics yet fail to change clinical results. Here, the improvement in frozen embryo transfer outcomes suggests that the model’s predictions translate into genuinely better choices about which embryos to place into patients.

The study builds on a growing body of work applying artificial intelligence to embryo assessment. Earlier efforts by some of the same authors developed an artificial intelligence model for predicting blastocyst euploidy specifically within PGT-A treatment cycles, where genetic results are available to train and validate algorithms. Other groups have compared deep learning-based embryo selection against manual morphology assessment in randomized trials, and meta-analyses of thousands of embryos have examined how morphological and morphokinetic features correlate with aneuploidy. Time-lapse imaging studies have identified specific dynamic events, such as blastocyst contractions, that associate with chromosomal abnormality and reduced implantation potential. The new work extends this lineage into territory where genetic ground truth is unavailable at the point of care, which is precisely where the clinical need is greatest.

The implications reach well beyond China’s regulatory landscape. Even in countries where PGT-A is freely available, the procedure adds cost, requires embryo biopsy, and remains debated, with large randomized trials yielding mixed conclusions about whether it improves live birth rates per transfer cycle started. A validated non-invasive predictor could serve as a triage tool everywhere, helping clinics prioritize embryos for transfer or for biopsy, sparing patients unnecessary procedures, and potentially reducing the number of embryos subjected to manipulation. Because the model relies on development dynamics, morphology and maternal age, data captured in virtually every modern IVF laboratory, adoption barriers would be low compared with approaches requiring new imaging hardware or genetic assays.

Caution is still warranted. A model with 77 percent accuracy and a 27 percent false negative rate is a powerful aid to decision-making, not a replacement for genetic diagnosis when a definitive answer is required, and the authors themselves frame the tool as a way to select euploid embryos as far as possible rather than with certainty. External validation across diverse patient populations, laboratory protocols and imaging systems will be essential before widespread deployment, and the field has seen predictive models falter when moved between centers. Nevertheless, the study represents a concrete step toward a long-sought goal: choosing the best embryo for transfer using only what the embryo reveals about itself, non-invasively, as it grows. For the millions of couples undergoing IVF worldwide, an algorithm that quietly reads the developmental story of each blastocyst and tips the odds toward a healthy pregnancy is a development worth watching closely.

Subject of Research: Machine learning prediction of euploid blastocysts in IVF without preimplantation genetic testing for aneuploidy

Article Title: The Building and Application of a Machine Learning Model on Predicting Euploid Blastocysts in IVF Treatments Without PGT-A

Article References: Yuan, Z., Shao, J., Wen, Y., Yuan, M., Bai, M., Song, X., & Huang, X. (2026). The Building and Application of a Machine Learning Model on Predicting Euploid Blastocysts in IVF Treatments Without PGT-A. Reproductive Sciences. https://doi.org/10.1007/s43032-026-02230-4

Image Credits: AI Generated

DOI: 10.1007/s43032-026-02230-4

Keywords: IVF, machine learning, euploid blastocyst, PGT-A, aneuploidy, embryo selection, logistic regression, morphokinetics, blastocyst morphology, frozen embryo transfer, reproductive medicine, non-invasive prediction